Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
4
×
boston blog main
clinical trials
investing
4
×
life sciences
national blog main
boston top stories
deals
national top stories
fda
san francisco blog main
startups
akouos
allosteric
antisense oligonucleotide
astellas pharmaceuticals
atlas venture
atopic dermatitis
autoimmune disorders
avapritinib
benzodiazepines
biogen
blackstone group
blackstone life sciences
blueprint medicines
brace pharma
california institute for biomedical research
cleva pharma
columbia university
cstone pharmaceuticals
david goldstein
decibel therapeutics
depression
drug discovery
dupilumab
eli lilly
epi4k
epilepsy
essential tremor
What
medicines
4
×
drug
fda
new
therapeutics
address
adds
affects
ago
aims
allosteric
americans
approval
approved
backed
blueprint
cancer
candidate
cause
ceo
clinic
currently
date
developing
disease
drugs
elusive
epilepsy
frequency
genes
genetic
hearing
hotspot
ipo
links
loss
marcio
marketing
meds
millions
Language
unset
Current search:
investing
×
boston
×
medicines
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds